Sodium Tetradecyl Sulfate

CHEMBL1200354 Phase 4 Одобрено Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
316.4 g/mol
LogP
Phase
4

Sodium tetradecyl sulfate is a detergent-class sclerosing agent used for the treatment of varicose veins and hemorrhoids by injecting directly into the vessel lumen, causing endothelial damage, thrombosis, and subsequent fibrosis to obliterate the vein. By disrupting the endothelial cell lipid bilayer, it triggers an inflammatory response leading to sclerosis and permanent closure of the target vessel. It is used in sclerotherapy as an alternative to surgical vein stripping.

Молекулярная масса

316,4300 g/mol

TPSA

74,80 Ų

Терапевтические области

Механизм действия

Causes endothelial damage and inflammation when injected into a vessel, leading to thrombosis, fibrosis, and eventual obliteration of the treated vein or vascular malformation.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Механизм

Causes endothelial damage and inflammation when injected into a vessel, leading to thrombosis, fibrosis, and eventual obliteration of the treated vein or vascular malformation.

2D Структура

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCCC(CC)CCC(CC(C)C)OS(=O)(=O)[O-].[Na+]

InChI

InChI=1S/C14H30O4S.Na/c1-5-7-8-13(6-2)9-10-14(11-12(3)4)18-19(15,16)17;/h12-14H,5-11H2,1-4H3,(H,15,16,17);/q;+1/p-1

Molecular Formula

C14H29NaO4S

HBD / HBA

- / 4

Вращаемые Связи

11

Тяжёлые Атомы

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Часто задаваемые вопросы

Sodium tetradecyl sulfate is a detergent-class sclerosing agent used for the treatment of varicose veins and hemorrhoids by injecting directly into the vessel lumen, causing endothelial damage, thrombosis, and subsequent fibrosis to obliterate the vein. By disrupting the endothelial cell lipid bilayer, it triggers an inflammatory response leading to sclerosis and permanent closure of the target vessel. It is used in sclerotherapy as an alternative to surgical vein stripping.

Causes endothelial damage and inflammation when injected into a vessel, leading to thrombosis, fibrosis, and eventual obliteration of the treated vein or vascular malformation.

Yes, Sodium Tetradecyl Sulfate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200354. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23665772. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Медицинский отказ от ответственности

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.